Literature DB >> 3765030

Red cell autoantibodies in patients with acquired immune deficiency syndrome.

M H McGinniss, A M Macher, A H Rook, H J Alter.   

Abstract

Mild-to-profound anemia, thrombocytopenia, and rarely neutropenia have been observed in patients with the acquired immune deficiency syndrome (AIDS). To investigate a possible immune mechanism, blood samples from 28 hospitalized AIDS patients, four asymptomatic homosexual men, four homosexual men with the AIDS-related lymphadenopathy syndrome, 30 hospitalized patients with diseases other than AIDS, and 60 blood donors were tested for the presence of atypical red cell antibodies. Eighteen AIDS patients (64%) had anti-i, nine (32%) had autoanti-U, and 12 (43%) had a positive direct antiglobulin test. One asymptomatic homosexual man and three homosexual men with lymphadenopathy also had anti-i. In contrast, of the 30 patients with diseases other than AIDS and 60 donors, none had anti-U or a positive direct antiglobulin test. One patient with sickle cell disease had anti-i. The mean hemoglobin level of AIDS patients with anti-i or anti-U was significantly lower than the mean hemoglobin level of patients who did not have those antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3765030     DOI: 10.1046/j.1537-2995.1986.26587020112.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  Erythrocyte antibodies in AIDS are associated with mycobacteriosis and hypergammaglobulinemia.

Authors:  J R Bogner; B Gathof; B Heinrich; A Matuschke; U Bäcker; F D Goebel
Journal:  Klin Wochenschr       Date:  1990-11-09

Review 2.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

3.  Cold agglutinins in haemophiliac boys infected with HIV.

Authors:  P H Bolton-Maggs; P D Rogan; J K Duguid; K J Mutton; L M Ball
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

4.  Clinical significance of positive direct antiglobulin test in patients with HIV infection.

Authors:  V De Angelis; C Biasinutto; P Pradella; E Vaccher; M Spina; U Tirelli
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Haemoglobin and anaemia in the SMART study.

Authors:  Amanda Mocroft; Alan R Lifson; Giota Touloumi; Jacqueline Neuhaus; Zoe Fox; Adrian Palfreeman; Michael J Vjecha; Sally Hodder; Stephane De Wit; Jens D Lundgren; Andrew N Phillips
Journal:  Antivir Ther       Date:  2011

Review 6.  Endogenous retroviral pathogenesis in lupus.

Authors:  Andras Perl; David Fernandez; Tiffany Telarico; Paul E Phillips
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

7.  A Study of Clinical and Serological Correlation of Positive Direct Antiglobulin Test in Blood Bank at a Tertiary Care Center.

Authors:  Alisha Suresh Kerkar; Swarupa Nikhil Bhagwat; Jayashree Harihara Sharma
Journal:  J Lab Physicians       Date:  2022-01-18

Review 8.  Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.

Authors:  Andras Perl; Gyorgy Nagy; Agnes Koncz; Peter Gergely; David Fernandez; Edward Doherty; Tiffany Telarico; Eduardo Bonilla; Paul E Phillips
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

9.  Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen.

Authors:  Simbarashe Takuva; Mhairi Maskew; Alana T Brennan; Ian Sanne; A Patrick Macphail; Mathew P Fox
Journal:  J Trop Med       Date:  2013-08-27

10.  Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.

Authors:  Rachel Kyeyune; Elmar Saathoff; Amara E Ezeamama; Thomas Löscher; Wafaie Fawzi; David Guwatudde
Journal:  BMC Infect Dis       Date:  2014-09-10       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.